![A Vall d'Hebron project receives the N-ECCO grant awarded by the European Crohn's and Ulcerative Colitis Organization | Vall d'Hebron Barcelona Hospital Campus A Vall d'Hebron project receives the N-ECCO grant awarded by the European Crohn's and Ulcerative Colitis Organization | Vall d'Hebron Barcelona Hospital Campus](https://www.vallhebron.com/sites/default/files/styles/crop_16_9_large/public/2023-03/guanyadors-ecco-2023.jpg?itok=CG8dlAsd)
A Vall d'Hebron project receives the N-ECCO grant awarded by the European Crohn's and Ulcerative Colitis Organization | Vall d'Hebron Barcelona Hospital Campus
![12th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology 12th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology](https://www.esp-pathology.org/_Resources/Persistent/ac53b796218c5b837763c09492b2107fa2791497/170907_v2_ECCO%2717%20Web%20banner_150x100.jpg)
12th Congress of ECCO - Congresses/Courses/Workshops/ Events - Events - Events & Newsroom - The European Society of Pathology
![Y-ECCO on Twitter: "Our ECCO President @Julian Panes updates the @my_ueg #IBD community on the use of MSCs - results of the ASTIC study #Uegweek # ECCO-IBD https://t.co/gPB4lrFjeu" / Twitter Y-ECCO on Twitter: "Our ECCO President @Julian Panes updates the @my_ueg #IBD community on the use of MSCs - results of the ASTIC study #Uegweek # ECCO-IBD https://t.co/gPB4lrFjeu" / Twitter](https://pbs.twimg.com/media/DNiORUyXcAAa_5u.jpg)
Y-ECCO on Twitter: "Our ECCO President @Julian Panes updates the @my_ueg #IBD community on the use of MSCs - results of the ASTIC study #Uegweek # ECCO-IBD https://t.co/gPB4lrFjeu" / Twitter
Dal contratto monstre di Messi al debito esploso fino alle scadenze da onorare in fretta: ecco perché il Barcellona può fallire davvero - Il Fatto Quotidiano
![Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease | SpringerLink Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10620-019-06036-0/MediaObjects/10620_2019_6036_Fig1_HTML.png)